Africa Centres for Disease Control and Prevention's framework for antimicrobial resistance control in Africa

Jay K Varma¹, John Oppong-Otoo², Pascale Ondoa³, Olga Perovic^{4

5}, Benjamin J Park⁶, Ramanan Laxminarayan^{7

8}, Rosanna W Peeling⁹, Constance Schultsz¹⁰, Han Li^{11

12}, Chikwe Ihekweazu¹³, Amadou A Sall¹⁴, Baboucarr Jaw², John N Nkengasong¹

Affiliations

¹ Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.
² African Union, Inter-African Bureau for Animal Resources, Nairobi, Kenya.
³ African Society for Laboratory Medicine, Addis Ababa, Ethiopia.
⁴ National Institute for Communicable Diseases, Johannesburg, South Africa.
⁵ University of Witwatersrand, Johannesburg, South Africa.
⁶ United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States.
⁷ Center for Disease Dynamics, Economics and Policy, Washington, D.C., United States.
⁸ Princeton University, Princeton, New Jersey, United States.
⁹ London School of Tropical Medicine and Hygiene, London, England, United Kingdom.
¹⁰ Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands.
¹¹ China Center for Disease Control and Prevention, Beijing, China.
¹² China PLA Institute for Disease Control and Prevention, Beijing, China.
¹³ Nigeria Center for Disease Control, Abuja, Nigeria.
¹⁴ Institut Pasteur, Dakar, Senegal.

Jay K Varma et al. Afr J Lab Med. 2018.

. 2018 Dec 6;7(2):830.

doi: 10.4102/ajlm.v7i2.830. eCollection 2018.

¹ Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.
² African Union, Inter-African Bureau for Animal Resources, Nairobi, Kenya.
³ African Society for Laboratory Medicine, Addis Ababa, Ethiopia.
⁴ National Institute for Communicable Diseases, Johannesburg, South Africa.
⁵ University of Witwatersrand, Johannesburg, South Africa.
⁶ United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States.
⁷ Center for Disease Dynamics, Economics and Policy, Washington, D.C., United States.
⁸ Princeton University, Princeton, New Jersey, United States.
⁹ London School of Tropical Medicine and Hygiene, London, England, United Kingdom.
¹⁰ Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands.
¹¹ China Center for Disease Control and Prevention, Beijing, China.
¹² China PLA Institute for Disease Control and Prevention, Beijing, China.
¹³ Nigeria Center for Disease Control, Abuja, Nigeria.
¹⁴ Institut Pasteur, Dakar, Senegal.

No abstract available

Conflict of interest statement

The authors declare that they have no financial or personal relationships which may have inappropriately influenced them in writing this article.

1. World Bank Drug-resistant infections: A threat to our economic future [homepage on the Internet]. Washington, DC; 2016. Available from: http://pubdocs.worldbank.org/en/689381474641399486/1701381-AMR-Lab-Repor...
1. Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13:1057–1098. https://doi.org/10.1016/S1473-3099(13)70318-9 - DOI - PubMed
1. Ndihokubwayo JB, Yahaya AA, Desta AT, et al. Antimicrobial resistance in the African region: Issues, challenges and actions proposed. Key determinants for health in the African region. African Health Monitor. 2013;16.
1. World Health Organization Drug resistant tuberculosis is now at record levels [homepage on the Internet]. Geneva; 2010. Available from: http://www.who.int/mediacentre/news/releases/2010/drug_resistant_tb_2010...
1. Essack SY, Desta AT, Abotsi RE, Agoba EE. Antimicrobial resistance in the WHO African region: Current status and roadmap for action. J Pub Health. 2016;39:8–13. https://doi.org/10.1093/pubmed/fdw015 - DOI - PMC - PubMed